We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$1.08B
AUM Growth
+$48M
Cap. Flow
+$5.56M
Cap. Flow %
0.52%
Top 10 Hldgs %
38.16%
Holding
167
New
11
Increased
57
Reduced
52
Closed
10

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$12.7M
2
AXP icon
American Express
AXP
+$12.3M
3
MAR icon
Marriott International
MAR
+$9.25M
4
ECL icon
Ecolab
ECL
+$7.04M
5
KO icon
Coca-Cola
KO
+$6.3M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$13.1M
2
DG icon
Dollar General
DG
+$10.8M
3
PARA
Paramount Global Class B
PARA
+$9.78M
4
PFE icon
Pfizer
PFE
+$7.15M
5
MCD icon
McDonald's
MCD
+$7.1M

Sector Composition

Rank Sector Weight
1 Technology 24.13%
2 Financials 17.57%
3 Healthcare 13.09%
4 Consumer Discretionary 12.62%
5 Communication Services 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
101
Capital One
COF
$136B
$578K 0.05%
4,540
PTGX icon
102
Protagonist Therapeutics
PTGX
$8.73B
$576K 0.05%
22,250
DOW icon
103
Dow Inc
DOW
$21.9B
$572K 0.05%
8,946
CMCSA icon
104
Comcast
CMCSA
$88.5B
$531K 0.05%
9,808
+1,555
+19% +$82.1K
DG icon
105
Dollar General
DG
$28.1B
$507K 0.05%
2,502
-54,539
-96% -$10.8M
GTHX
106
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$505K 0.05%
+21,000
New +$488K
BAC icon
107
Bank of America
BAC
$440B
$479K 0.04%
12,371
+349
+3% +$12K
ENB icon
108
Enbridge
ENB
$117B
$474K 0.04%
13,012
+1,061
+9% +$37.3K
DD icon
109
DuPont de Nemours
DD
$19.3B
$470K 0.04%
4,848
GS icon
110
Goldman Sachs
GS
$311B
$441K 0.04%
1,350
-135
-9% -$42K
TFC icon
111
Truist Financial
TFC
$64.3B
$428K 0.04%
7,336
-938
-11% -$51.4K
GSBD icon
112
Goldman Sachs BDC
GSBD
$1.01B
$415K 0.04%
+21,446
New +$402K
ABT icon
113
Abbott
ABT
$182B
$410K 0.04%
3,418
-93
-3% -$11K
SHW icon
114
Sherwin-Williams
SHW
$87.8B
$378K 0.04%
1,536
-471
-23% -$112K
SLCT
115
DELISTED
Select Bancorp, Inc.
SLCT
$360K 0.03%
+32,493
New +$345K
KYNB
116
Kyntra Bio
KYNB
$28M
$347K 0.03%
400
MAS icon
117
Masco
MAS
$15.2B
$347K 0.03%
5,796
CALA
118
DELISTED
Calithera Biosciences, Inc
CALA
$335K 0.03%
6,929
+1,300
+23% +$75.7K
FDX icon
119
FedEx
FDX
$74.1B
$313K 0.03%
1,103
-31
-3% -$7.99K
A icon
120
Agilent Technologies
A
$39.3B
$311K 0.03%
2,445
+55
+2% +$6.8K
NKTR icon
121
Nektar Therapeutics
NKTR
$2.46B
$310K 0.03%
1,033
SBR
122
Sabine Royalty Trust
SBR
$1.05B
$306K 0.03%
10,081
PNC icon
123
PNC Financial Services
PNC
$101B
$298K 0.03%
1,700
IFRX icon
124
InflaRx
IFRX
$262M
$293K 0.03%
75,100
+50,000
+199% +$256K
SONY icon
125
Sony
SONY
$131B
$289K 0.03%
13,610

Similar funds

Franklin Street Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Franklin Street Advisors held 167 positions worth $1.08B, up 4.7% from $1.03B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Franklin Street Advisors's Q1 2021 filing shows 11 new, 57 increased, 52 reduced and 10 closed positions. Its largest new stake was Marriott International: 67,714 shares worth $10M. The largest sale was Clorox, an estimated $13.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Franklin Street Advisors's largest Q1 2021 buy was Marriott International: 67,714 shares worth $10M.
  • Franklin Street Advisors added most to ExxonMobil in Q1 2021, an estimated $12.7M increase.
  • Franklin Street Advisors's biggest Q1 2021 reduction was Clorox, cutting an estimated $13.1M.
  • Franklin Street Advisors fully exited Paramount Global Class B in Q1 2021, selling an estimated $9.78M.
  • Franklin Street Advisors's ten largest holdings make up 38% of its $1.08B portfolio in Q1 2021.
  • Franklin Street Advisors opened 11 new positions and closed 10 in Q1 2021.
  • Franklin Street Advisors's portfolio value rose 4.7% quarter-over-quarter to $1.08B.

Based on Franklin Street Advisors's 13F filing for Q1 2021, filed 4 May 2021.